We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Daffodils to Treat Alzheimer's

By Biotechdaily staff writers
Posted on 29 Aug 2005
A substance found in daffodils, the national flower of Wales, may help treat patients with Alzheimer's disease (AD), the most common form of dementia that is accompanied by loss of memory.

Certain daffodil species, which thrive in the Black Mountains of eastern Wales, produce galanthamine, a drug designed to alleviate loss-of-memory symptoms. More...
The Manufacturing Engineering Center of Cardiff University (Wales, UK;) is helping to develop the agricultural potential of the daffodil as a medicinal plant, along with the Institute of Grassland and Environmental Research at the University of Wales, Aberystwyh (UK).

The center is providing support ranging from harvesting in the field to marketing the pharmaceutical product. This includes assisting with the science of developing crops more than once a year and helping growers to assess when is the best time to harvest the crop.

"Galanthamine has major investment potential,” stated Frank Marsh, marketing director of the Manufacturing Engineering Center. "Furthermore, the potential for Welsh hill farms is huge. The benefits are extensive, not only to Welsh bioscience and the pharmaceutical industry but also to the aging population.”





Related Links:
Cardiff University
Univ. of Wales, Aberystwyh

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.